Hitech Corporation Ltd: Share Price Analysis, Intrinsic Value & Fundamentals (2025)

Share Price and Basic Stock Data

Last Updated: March 8, 2025, 1:49 pm

Competitors of Hitech Corporation Ltd

All Competitor Stocks of Hitech Corporation Ltd

Quarterly Result

Last Updated: February 28, 2025, 7:28 pm

Below is a detailed analysis of the quarterly data for Hitech Corporation Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:

• For Sales, as of Dec 2024, the value is ₹123.00 Cr.. The value appears to be declining and may need further review. It has decreased from 146.51 Cr. (Sep 2024) to ₹123.00 Cr., marking a decrease of 23.51 Cr..
• For Expenses, as of Dec 2024, the value is ₹109.79 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 129.60 Cr. (Sep 2024) to ₹109.79 Cr., marking a decrease of 19.81 Cr..
• For Operating Profit, as of Dec 2024, the value is ₹13.21 Cr.. The value appears to be declining and may need further review. It has decreased from 16.91 Cr. (Sep 2024) to ₹13.21 Cr., marking a decrease of 3.70 Cr..
• For OPM %, as of Dec 2024, the value is 10.74%. The value appears to be declining and may need further review. It has decreased from 11.54% (Sep 2024) to 10.74%, marking a decrease of 0.80%.
• For Other Income, as of Dec 2024, the value is ₹0.97 Cr.. The value appears strong and on an upward trend. It has increased from 0.36 Cr. (Sep 2024) to ₹0.97 Cr., marking an increase of ₹0.61 Cr..
• For Interest, as of Dec 2024, the value is ₹3.90 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 4.10 Cr. (Sep 2024) to ₹3.90 Cr., marking a decrease of 0.20 Cr..
• For Depreciation, as of Dec 2024, the value is ₹9.06 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 9.09 Cr. (Sep 2024) to ₹9.06 Cr., marking a decrease of 0.03 Cr..
• For Profit before tax, as of Dec 2024, the value is ₹1.22 Cr.. The value appears to be declining and may need further review. It has decreased from 4.08 Cr. (Sep 2024) to ₹1.22 Cr., marking a decrease of 2.86 Cr..
• For Tax %, as of Dec 2024, the value is -16.39%. The value appears to be improving (decreasing) as expected. It has decreased from 28.68% (Sep 2024) to -16.39%, marking a decrease of 45.07%.
• For Net Profit, as of Dec 2024, the value is ₹1.43 Cr.. The value appears to be declining and may need further review. It has decreased from 2.92 Cr. (Sep 2024) to ₹1.43 Cr., marking a decrease of 1.49 Cr..
• For EPS in Rs, as of Dec 2024, the value is 0.83. The value appears to be declining and may need further review. It has decreased from ₹1.70 (Sep 2024) to 0.83, marking a decrease of ₹0.87.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: March 6, 2025, 4:02 pm

Balance Sheet

Last Updated: December 14, 2024, 3:29 pm

Below is a detailed analysis of the balance sheet data for Hitech Corporation Ltd based on the most recent figures (Sep 2024) and their trends compared to the previous period:

• For Equity Capital, as of Sep 2024, the value is ₹17.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded ₹17.00 Cr..
• For Reserves, as of Sep 2024, the value is ₹252.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹246.00 Cr. (Mar 2024) to ₹252.00 Cr., marking an increase of 6.00 Cr..
• For Borrowings, as of Sep 2024, the value is ₹88.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from ₹80.00 Cr. (Mar 2024) to ₹88.00 Cr., marking an increase of 8.00 Cr..
• For Other Liabilities, as of Sep 2024, the value is ₹47.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹45.00 Cr. (Mar 2024) to ₹47.00 Cr., marking an increase of 2.00 Cr..
• For Total Liabilities, as of Sep 2024, the value is ₹404.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from ₹389.00 Cr. (Mar 2024) to ₹404.00 Cr., marking an increase of 15.00 Cr..
• For Fixed Assets, as of Sep 2024, the value is ₹265.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹256.00 Cr. (Mar 2024) to ₹265.00 Cr., marking an increase of 9.00 Cr..
• For CWIP, as of Sep 2024, the value is ₹13.00 Cr.. The value appears to be declining and may need further review. It has decreased from ₹15.00 Cr. (Mar 2024) to ₹13.00 Cr., marking a decrease of 2.00 Cr..
• For Investments, as of Sep 2024, the value is ₹2.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹1.00 Cr. (Mar 2024) to ₹2.00 Cr., marking an increase of 1.00 Cr..
• For Other Assets, as of Sep 2024, the value is ₹124.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹117.00 Cr. (Mar 2024) to ₹124.00 Cr., marking an increase of 7.00 Cr..
• For Total Assets, as of Sep 2024, the value is ₹404.00 Cr.. The value appears strong and on an upward trend. It has increased from ₹389.00 Cr. (Mar 2024) to ₹404.00 Cr., marking an increase of 15.00 Cr..

Notably, the Reserves (₹252.00 Cr.) exceed the Borrowings (88.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Hitech Corporation Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 15, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 14) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 15, the value is 4.84. This value is below the healthy minimum of 5. It has increased from 4.82 (Mar 14) to 4.84, marking an increase of 0.02.
• For Diluted EPS (Rs.), as of Mar 15, the value is 4.25. This value is below the healthy minimum of 5. It has decreased from 4.82 (Mar 14) to 4.25, marking a decrease of 0.57.
• For Cash EPS (Rs.), as of Mar 15, the value is 15.25. This value is within the healthy range. It has decreased from 20.13 (Mar 14) to 15.25, marking a decrease of 4.88.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 15, the value is 98.49. It has decreased from 99.04 (Mar 14) to 98.49, marking a decrease of 0.55.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 15, the value is 98.49. It has decreased from 99.04 (Mar 14) to 98.49, marking a decrease of 0.55.
• For Revenue From Operations / Share (Rs.), as of Mar 15, the value is 306.30. It has decreased from 348.83 (Mar 14) to 306.30, marking a decrease of 42.53.
• For PBDIT / Share (Rs.), as of Mar 15, the value is 27.10. This value is within the healthy range. It has decreased from 37.29 (Mar 14) to 27.10, marking a decrease of 10.19.
• For PBIT / Share (Rs.), as of Mar 15, the value is 16.40. This value is within the healthy range. It has decreased from 23.30 (Mar 14) to 16.40, marking a decrease of 6.90.
• For PBT / Share (Rs.), as of Mar 15, the value is 6.00. This value is within the healthy range. It has decreased from 10.23 (Mar 14) to 6.00, marking a decrease of 4.23.
• For Net Profit / Share (Rs.), as of Mar 15, the value is 4.55. This value is within the healthy range. It has decreased from 6.14 (Mar 14) to 4.55, marking a decrease of 1.59.
• For NP After MI And SOA / Share (Rs.), as of Mar 15, the value is 4.62. This value is within the healthy range. It has decreased from 4.82 (Mar 14) to 4.62, marking a decrease of 0.20.
• For PBDIT Margin (%), as of Mar 15, the value is 8.84. This value is below the healthy minimum of 10. It has decreased from 10.68 (Mar 14) to 8.84, marking a decrease of 1.84.
• For PBIT Margin (%), as of Mar 15, the value is 5.35. This value is below the healthy minimum of 10. It has decreased from 6.67 (Mar 14) to 5.35, marking a decrease of 1.32.
• For PBT Margin (%), as of Mar 15, the value is 1.95. This value is below the healthy minimum of 10. It has decreased from 2.93 (Mar 14) to 1.95, marking a decrease of 0.98.
• For Net Profit Margin (%), as of Mar 15, the value is 1.48. This value is below the healthy minimum of 5. It has decreased from 1.76 (Mar 14) to 1.48, marking a decrease of 0.28.
• For NP After MI And SOA Margin (%), as of Mar 15, the value is 1.50. This value is below the healthy minimum of 8. It has increased from 1.38 (Mar 14) to 1.50, marking an increase of 0.12.
• For Return on Networth / Equity (%), as of Mar 15, the value is 5.89. This value is below the healthy minimum of 15. It has decreased from 6.37 (Mar 14) to 5.89, marking a decrease of 0.48.
• For Return on Capital Employeed (%), as of Mar 15, the value is 15.24. This value is within the healthy range. It has decreased from 18.55 (Mar 14) to 15.24, marking a decrease of 3.31.
• For Return On Assets (%), as of Mar 15, the value is 2.77. This value is below the healthy minimum of 5. It has increased from 2.37 (Mar 14) to 2.77, marking an increase of 0.40.
• For Long Term Debt / Equity (X), as of Mar 15, the value is 0.07. This value is below the healthy minimum of 0.2. It has decreased from 0.29 (Mar 14) to 0.07, marking a decrease of 0.22.
• For Total Debt / Equity (X), as of Mar 15, the value is 0.51. This value is within the healthy range. It has decreased from 0.77 (Mar 14) to 0.51, marking a decrease of 0.26.
• For Asset Turnover Ratio (%), as of Mar 15, the value is 1.79. It has increased from 1.23 (Mar 14) to 1.79, marking an increase of 0.56.
• For Current Ratio (X), as of Mar 15, the value is 1.31. This value is below the healthy minimum of 1.5. It has increased from 1.23 (Mar 14) to 1.31, marking an increase of 0.08.
• For Quick Ratio (X), as of Mar 15, the value is 1.02. This value is within the healthy range. It has increased from 0.89 (Mar 14) to 1.02, marking an increase of 0.13.
• For Inventory Turnover Ratio (X), as of Mar 15, the value is 10.46. This value exceeds the healthy maximum of 8. It has increased from 8.20 (Mar 14) to 10.46, marking an increase of 2.26.
• For Dividend Payout Ratio (NP) (%), as of Mar 15, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 18.66 (Mar 14) to 0.00, marking a decrease of 18.66.
• For Dividend Payout Ratio (CP) (%), as of Mar 15, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 4.78 (Mar 14) to 0.00, marking a decrease of 4.78.
• For Earning Retention Ratio (%), as of Mar 15, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 81.34 (Mar 14) to 0.00, marking a decrease of 81.34.
• For Cash Earning Retention Ratio (%), as of Mar 15, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 95.22 (Mar 14) to 0.00, marking a decrease of 95.22.
• For Interest Coverage Ratio (X), as of Mar 15, the value is 2.60. This value is below the healthy minimum of 3. It has decreased from 2.85 (Mar 14) to 2.60, marking a decrease of 0.25.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 15, the value is 1.43. This value is below the healthy minimum of 3. It has decreased from 1.47 (Mar 14) to 1.43, marking a decrease of 0.04.
• For Enterprise Value (Cr.), as of Mar 15, the value is 238.99. It has increased from 171.09 (Mar 14) to 238.99, marking an increase of 67.90.
• For EV / Net Operating Revenue (X), as of Mar 15, the value is 0.51. This value is below the healthy minimum of 1. It has increased from 0.37 (Mar 14) to 0.51, marking an increase of 0.14.
• For EV / EBITDA (X), as of Mar 15, the value is 5.81. This value is within the healthy range. It has increased from 3.48 (Mar 14) to 5.81, marking an increase of 2.33.
• For MarketCap / Net Operating Revenue (X), as of Mar 15, the value is 0.32. This value is below the healthy minimum of 1. It has increased from 0.14 (Mar 14) to 0.32, marking an increase of 0.18.
• For Retention Ratios (%), as of Mar 15, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 81.33 (Mar 14) to 0.00, marking a decrease of 81.33.
• For Price / BV (X), as of Mar 15, the value is 1.26. This value is within the healthy range. It has increased from 0.66 (Mar 14) to 1.26, marking an increase of 0.60.
• For Price / Net Operating Revenue (X), as of Mar 15, the value is 0.32. This value is below the healthy minimum of 1. It has increased from 0.14 (Mar 14) to 0.32, marking an increase of 0.18.
• For EarningsYield, as of Mar 15, the value is 0.04. This value is below the healthy minimum of 5. It has decreased from 0.09 (Mar 14) to 0.04, marking a decrease of 0.05.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness